The Latest Breaking News from JNJ

With strong job growth, unexpected inflation, and robust retail sales, the Fed’s tight monetary policy could stay in place for some time. Amid volatilities and anxiety soaring, fundamentally strong stocks Johnson & Johnson (JNJ) and Cisco Systems (CSCO) might be solid portfolio additions now. Read on….

The pharma industry witnessed solid growth amid the pandemic. Moreover, with surging demand, rising investments in research and development, and increasing e-pharmacy channels, the industry is well-positioned for significant growth over the coming years. Therefore, investors could consider buying fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

As inflation is still at an alarmingly high level, the Fed is expected to continue with its rate hikes this year. However, experts see chances of the economy evading a recession. Therefore, it could be wise to buy quality stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Walmart (WMT) now…

Although favorable macro data rekindled investor optimism, the Fed’s intention of raising rates to tame stubbornly high inflation could possibly tip the economy into recession. With anxiety escalating, it would be wise to add quality stocks Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) to your portfolio to sail through…

Receding inflationary pressure and the Fed’s smaller rate hike have raised investor optimism. However, amid additional rate hike fears and associated volatilities, investors could scoop up quality stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and AstraZeneca (AZN) that could help them build wealth in the market. Read on….

The stock market witnessed a decent rally in January, with cooling inflationary pressures reducing recession fears. However, the Fed’s attempts to bring inflation down to its 2% target could hurt economic growth. Hence, it could be wise to invest in shares of Johnson & Johnson (JNJ), Novartis (NVS), and LCNB…

With a recession expected this year due to the Fed’s hawkish stance, investors could look to buy fundamentally strong dividend-paying stocks Johnson & Johnson (JNJ), Kroger (KR), and Bluegreen Vacations Holding (BVH). Keep reading….

Despite cooling inflation, the Fed’s indication of continuing its hawkish stance and recession concerns could keep the stock market volatile for a while. Against this backdrop, fundamentally sound dividend stocks trading under $200, Johnson & Johnson (JNJ), Archer-Daniels-Midland (ADM), and Acuity Brands (AYI) might be solid buys for investors’ retirement…

The Fed’s intention to continue raising interest rates, disappointing economic data, and a weak earnings season could keep the stock market highly volatile. Hence, investing in quality stocks Microsoft (MSFT), Johnson (JNJ), and Novartis (NVS) could be safe. Continue reading.

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

With the Fed’s progressive interest-rate hikes keeping markets in perpetual turmoil, strong fundamentals of Johnson & Johnson (JNJ) could help investors secure decent risk-adjusted returns on their investments. Read on….